首页 | 本学科首页   官方微博 | 高级检索  
     


Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease
Authors:Tashkin Donald P,Elashoff Robert,Clements Philip J,Roth Michael D,Furst Daniel E,Silver Richard M,Goldin Jonathan,Arriola Edgar,Strange Charlie,Bolster Marcy B,Seibold James R,Riley David J,Hsu Vivien M,Varga John,Schraufnagel Dean,Theodore Arthur,Simms Robert,Wise Robert,Wigley Fred,White Barbara,Steen Virginia,Read Charles,Mayes Maureen,Parsley Ed,Mubarak Kamal,Connolly M Kari,Golden Jeffrey,Olman Mitchell,Fessler Barri,Rothfield Naomi,Metersky Mark,Khanna Dinesh,Li Ning,Li Gang  Scleroderma Lung Study Research Group
Affiliation:Department of Medicine, David Geffen School of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095-1690, USA. dtashkin@mednet.ucla.edu
Abstract:
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号